# A Randomized, Double Blind, Placebo Controlled Trial L-carnitine and Piracetam in the Treatment of Weakness, Muscle Fatigue and Muscle Pain in the Postpoliomyelitis Syndrome

> **NCT01549847** · PHASE3 · WITHDRAWN · sponsor: **Biolab Sanus Farmaceutica**

## Conditions studied

- Postpoliomyelitis Syndrome

## Interventions

- **DRUG:** L-carnitine and piracetam
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01549847
- **Lead sponsor:** Biolab Sanus Farmaceutica
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** 2013-02
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study was not approved by Health Surveillance Agency
- **Last updated:** 2015-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01549847

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01549847, "A Randomized, Double Blind, Placebo Controlled Trial L-carnitine and Piracetam in the Treatment of Weakness, Muscle Fatigue and Muscle Pain in the Postpoliomyelitis Syndrome". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01549847. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*